NCT00235885View on ClinicalTrials.gov

Safety and Efficacy Study of Adalimumab in Patients With Active Psoriatic Arthritis (PsA)

PHASE3CompletedINTERVENTIONAL
Enrollment

445

Participants

Timeline

Start Date

July 31, 2005

Conditions
Psoriatic Arthritis
Interventions
DRUG

adalimumab

Trial Locations (1)

60064

Global Medical Information - Abbott, Abbott Park

Sponsors

Lead Sponsor

Abbott
All Listed Sponsors
lead

Abbott

INDUSTRY